In Q4, we launched our first TV commercial ... of potential COPD patients and physicians. We believe roughly 1/3 of patients treated in 2024 started their journey to treatment with our website ...

Betting has exploded out of the shadows and into the mainstream, but significant challenges remain to keep the industry on ...

Compounded GLP-1s have become more widespread, but are they safe? Some argue that compounding is nothing new, while others ...

Stocks like Ola Electric Mobility, Grasim Industries, RHI Magnesita India, Apollo Hospitals Enterprise, Walchandnagar ...

Biologics are typically prescribed for severe asthma when conventional treatments are insufficient. Phosphodiesterase-4 Inhibitors: Primarily used for COPD, these drugs, such as roflumilast, help ...

More than a decade after earning FDA approval for Xiaflex as a nonsurgical treatment option for Dupuytren’s contracture, Endo ...

Recent medical research reveals promising developments in the treatment of patients suffering from both diabetes and chronic obstructive pulmonary disease. The study, involving nearly 394,000 ...

Ohtuvayre TM (ensifentrine) is the Company's first commercial product and the first inhaled therapy for the maintenance treatment of COPD that combines bronchodilator and non-steroidal ...

COPD affects the lungs and their ability to ... which is life-threatening with no cure. The new treatment, the Zephyr Valve, aims to help ease the quality of life for patients and aid in breathing.

St. Vincent’s Riverside is now offering a breakthrough treatment for patients diagnosed with chronic pulmonary obstructive disease (COPD)/emphysema. COPD affects the lungs and their ability to ...

Nearly two decades ago, Speciale, then a senior media buyer at MediaVest who negotiated prices and terms for commercial time, approached TV networks with an intriguing idea: Why couldn’t her ...